United States· US:77008-6751_4731bd97-8a64-f714-e063-6394a90ae6a4
Gaezoa Cream
A medicinal product containing camellia sinensis leaf; hyaluronic acid; glycerin, registered in United States by BIOHERB Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CAMELLIA SINENSIS LEAF; HYALURONIC ACID; GLYCERIN
- Manufacturer
- BIOHERB Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1177008675111 g in 1 PACKAGE (77008-6751-1)
- ndc1177008-6751-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2ef87a8-cacb-4188-acd0-7c9e95c5ef33 GET /v1/drugs/a2ef87a8-cacb-4188-acd0-7c9e95c5ef33?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "3.2; .64; 16",
"substance": "CAMELLIA SINENSIS LEAF; HYALURONIC ACID; GLYCERIN",
"productndc": "77008-6751",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about camellia sinensis leaf; hyaluronic acid; glycerin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.